PIM Designation Recognizes Molgramostim as a Promising Candidate for the UK Early Access to Medicines Scheme (EAMS) – A Program that Aims to Give Patients with Life Threatening or Seriously Debilitating Conditions with Unmet Medical Need Access to Medicines That Do Not Yet Have Marketing Au
Permanent link to this press release:
Delete press release Edit press rele
Get Sample Report Buy Complete Report
New Jersey (United States) – The Home Tonometer Market research report provides all the information related to the industry. It gives the market’s outlook by giving authentic data to its client, which helps to make essential decisions.�
Click here to sign in with or
Neuro-ophthalmologists highlight advances in the subspecialty over the past 20 years, including new classifications and treatments for optic neuritis, neuromyelitis optica spectrum disorder, and technological tools that have led to earlier detection of these and other disorders.
The new
One in 13 people in the U.S. have asthma, according to the Asthma and Allergy Foundation of America, and more than 15 million Americans deal with COPD or chronic obstructive pulmonary disease (per the CDC). While asthma can cause coughing, shortness of breath, and pain in the chest, COPD can
Anne is a visionary residency-trained, board-certified pharmacy leader with more than 10 years of healthcare experience. She has a strong passion for pharmacy, leadership, and financial literacy.
Erika Prouty, PharmD, is a professional community pharmacist who aids patients in medication
Carrie Yuan PharmD is a board-certified ambulatory care pharmacist. She is a clinical pharmacist in the Family Medicine Clinic at Harborview Medical Center in Seattle and a clinical associate professor at the University of Washington School of Pharmacy.
Alex Yampolsky, PharmD, is a clini
Home News Telemedicine Strengthens Glaucoma Diagnosis and Management back to News
January is Glaucoma Awareness Month. Glaucoma is the leading cause of permanent vision loss worldwide. There is no cure for glaucoma, but vision loss can be prevented through routine eye screeni
NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company utilizing the Company's proprietary and patented low intensity surface acoustic wave (SAW) technology, today provided the following business update in a letter to shareholders from its Chief Executive Officer, Brian Murphy: